TRUALT TruAlt Bioenergy Q2 FY26 results (Jul–Sep 2025) and concall
TruAlt Bioenergy reported muted Q2 FY26 results with significant revenue declines, primarily attributed to a strategic plant shutdown for dual-feed integration. Despite this, the company highlighted robust growth in its CBG segment and substantial cost savings from transitioning to bagasse-based power. Management emphasized a strategic transformation towards year-round, multi-feed operations and aggressive expansion into CBG, Sustainable Aviation Fuel (SAF), and retail fuel networks, projecting improved profitability and sustained growth in the coming periods.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|
| Revenue | 415 | 907 | 304 | 115 |
| EBITDA | 125 | 154 | 42 | -5 |
| Net profit | 75 | 112 | 5 | -38 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
